Atlas Trials

E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C

Clinical trial NCT03623750 · COMPLETED

Trial details

NCT number
NCT03623750
Sponsor
Instituto Oncológico Dr Rosell
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2018-07-06
Primary completion
2020-03-26
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.